Aragon Pharmaceuticals Receives $49,999,988 Series D Round

  • Feed Type
  • Date
    9/26/2012
  • Company Name
    Aragon Pharmaceuticals
  • Mailing Address
    12780 El Camino Real San Diego, CA 92130
  • Company Description
    Aragon Pharmaceuticals is a San Diego based biopharmaceutical company focused on developing a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers.
  • Website
    http://www.aragonpharmaceuticals.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $49,999,988
  • Transaction Round
    Series D
  • Proceeds Purposes
    This financing combined with our raise earlier this year provides Aragon with the resources to advance our pipeline, including ARN-509 for which we just recently announced promising Phase II results in prostate cancer patients.
  • M&A Terms
  • Venture Investor
    venBio
  • Venture Investor
    Topspin Partners
  • Venture Investor
    OrbiMed Advisors
  • Venture Investor
    Aisling Capital
  • Venture Investor
    The Column Group